Profil
Hy Isenbaum is the Founder of Soberman, Isenbaum and Colomby and served as its Managing Partner until 1993.
He served as Chairman of Bioniche Life Sciences, Inc. until May 9, 2008.
He is a past Chairman of the Board of the Mount Sinai Hospital in Toronto and was appointed by the Ontario Ministry of Health as Ombudsman to the Medical Review Committee of the College of Physicians and Surgeons.
Currently, he serves on the Board of Directors of the Samuel Lumenfeld Research Institute in Toronto and is a Governor of the Weizman Institute of Science in Israel.
Mr. Isenbaum is a Chartered Accountant.
Postes actifs de Hy Isenbaum
| Sociétés | Poste | Début |
|---|---|---|
Lunenfeld-Tanenbaum Research Institute
Lunenfeld-Tanenbaum Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in the provision of biomedical research services | Directeur/Membre du Conseil | - |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 09/07/2009 |
Anciens postes connus de Hy Isenbaum
| Sociétés | Poste | Fin |
|---|---|---|
| TELESTA THERAPEUTICS INC | Président | 09/05/2008 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Telesta Therapeutics, Inc.
Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches and develops pharmaceutical products for the human and veterinary markets | Health Technology |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lunenfeld-Tanenbaum Research Institute
Lunenfeld-Tanenbaum Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in the provision of biomedical research services | Commercial Services |
















